Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Focal ExAblate™ MR-Guided Focused Ultrasound (MRgFUS) Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (OC-IRPC): Evaluation of Safety and Effectiveness

NCT02968784 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT02968784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Focal ExAblate™ MR-Guided Focused Ultrasound (MRgFUS) Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (OC-IRPC): Evaluation of Safety and Effectiveness
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2016
Completion date
February 2, 2023
Enrollment
53 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer